Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies
Journal of Pharmacy and Pharmacology · 01.08.2024 · 76 (8) · 967-982
DOI: 10.1093/jpp/rgae041 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.08.2024. Verfasst von Saeid Iranzadeh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Faculty of Medicine, Shahed University, Tehran, Iran. Hauptthemen laut MEDLINE: Naphthoquinones, Breast Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
Breast cancer is a prevalent disease that has a substantial impact on women’s mortality rates. Shikonin, a naphthoquinone derived from Lithospermum erythrorhizon, has demonstrated substantial anticancer effects. This study aims to conduct a comprehensive review of the latest research findings regarding the therapeutic efficacy of shikonin in the context of breast cancer treatment, with a specific emphasis on elucidating the underlying molecular mechanisms.
Methods
A comprehensive literature review was conducted on shikonin and breast cancer by searching PubMed, Scopus, Web of Science, and Google Scholar databases. Key findings Shikonin significantly reduces tumor cell viability, proliferation, migration, invasion, and metastasis in both in vivo and in vitro across all breast cancer subtypes. Additionally, when combined with other pharmaceutical agents, it exhibits synergistic effects. Shikonin stimulates immunogenic cell death, resulting in apoptosis and necroptosis. The induction of immunogenic cell death by shikonin enhances the immunogenicity of breast cancer cells, leading to its involvement in the development of dendritic cell-based tumor vaccines against breast cancer.
Conclusion
Shikonin exhibits potent anti-breast cancer properties and shows significant potential for the advancement of immunotherapeutic approaches against breast cancer, as well as enhancing the efficacy of conventional treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Faculty of Medicine, Shahed University, Tehran, Iran.
ORCID-Profile: Saeid Iranzadeh
Zitieren
APA
Iranzadeh, S., Dalil, D., Kohansal, S., & Isakhani, M. (2024). Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies. Journal of Pharmacy and Pharmacology, 76(8), 967-982. https://doi.org/10.1093/jpp/rgae041
Vancouver
Iranzadeh S, Dalil D, Kohansal S, Isakhani M. Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies. Journal of Pharmacy and Pharmacology. 2024;76(8):967-982. doi:10.1093/jpp/rgae041
BibTeX
@article{Iranzadeh2024,
author = {Iranzadeh, Saeid and Dalil, Davood and Kohansal, Soroush and Isakhani, Mahdi},
title = {Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
volume = {76},
number = {8},
pages = {967--982},
doi = {10.1093/jpp/rgae041}
}
EUVIMED